诺华公司的该药物在美国市场的商品名为Gilenya。
Novartis will sell its drug under the brand name Gilenya in the U.S..
诺华公司称，该产品将很快在美国药房上架，它于去年年底报批欧盟。
Novartis said the product should be available in US pharmacies soon. It was submitted for approval in the European Union late last year.
该研究由瑞士巴塞尔的诺华公司资助，今天在亚特兰大的美国心脏病学会年会上公布并在新英格兰医学杂志上发表。
The study, funded by Basel, Switzerland-based Novartis, was presented today at the American College of Cardiology's annual meeting in Atlanta and appears in the New England Journal of Medicine.
产品网站的信息，这是对于非美国居民仅是由诺华公司提供动物健康的目的只是一般。
Product information on this website is for Non-US residents only and is provided by Novartis Animal Health Inc. for general purposes only.
蒋伟东，美国泰科诺华公司，大中国区总经理。
蒋伟东，美国泰科诺华公司，大中国区总经理。
应用推荐